The latest report by IMARC Group, titled “In Vitro Fertilization Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global in vitro fertilization market size reached US$ 22.43 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 37.24 Billion by 2028, exhibiting a growth rate (CAGR) of 8.50% during 2023-2028. In Vitro Fertilization (IVF) is a medical procedure designed to assist couples or individuals struggling with infertility in achieving pregnancy. It involves a series of carefully orchestrated steps conducted within a controlled laboratory environment. First, the woman undergoes ovulation stimulation through the administration of fertility medications, encouraging the ovaries to produce multiple eggs. Once these eggs reach maturity, a minor surgical procedure known as egg retrieval is performed to collect them from the ovaries. Subsequently, the retrieved eggs are combined with sperm, either from the partner or a donor, in the laboratory. These fertilized eggs, now referred to as embryos, are closely monitored as they develop over several days. Then, the healthiest embryos are selected and transferred into the woman's uterus, with the hope that they will be implanted and lead to a successful pregnancy. At present, IVF is gaining immense traction across the globe due to its effectiveness in addressing infertility issues. For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/in-vitro-fertilization-market/requestsample In Vitro Fertilization Market Trends and Drivers: The global In-vitro fertilization market is primarily driven by the increasing prevalence of infertility issues among couples owing to various lifestyle factors, such as delayed parenthood and stress. IVF procedures offer hope for couples struggling with infertility. Additionally, ongoing advancements in assisted reproductive technologies, including the development of more effective and less invasive IVF techniques, are positively influencing market growth. Apart from this, the rising acceptance of single-parent families and same-sex couples seeking fertility treatment has catalyzed market growth. Moreover, the shifting trend toward delaying childbirth, especially in developed countries, has escalated the demand for IVF services. Besides this, the heightening awareness and accessibility of fertility treatments and improved success rates is another major growth-inducing factor. Furthermore, several supportive government initiatives and insurance coverage for fertility treatments in some regions that make IVF more accessible to a broader population are contributing to market growth. Other factors, including increasing demand for elective fertility preservation among individuals and couples, growing medical tourism for IVF procedures, and ongoing advancements in genetic screening techniques, are also anticipated to drive the market further in the coming years. Report Segmentation: The report has segmented the market into the following categories: Product Insights:
- Reagent
- Cryopreservation Media
- Embryo Culture Media
- Ovum Processing Media
- Sperm Processing Media
- Instrument
- Imaging Systems
- Incubators
- Cryosystems
- IVF Cabinet
- Ovum Aspiration Pump
- Sperm Separation Systems
- Micromanipulator Systems
- Others
- Accessories
- Fresh Donor
- Frozen Donor
- Fresh Non-donor
- Frozen Non-donor
- Conventional IVF
- IVF with ICSI
- IVF with Donor Eggs
- Fertility Clinics
- Hospitals
- Others
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
- Boston IVF
- CooperSurgical Inc. (The Cooper Companies Inc.)
- Esco Micro Pte. Ltd
- FUJIFILM Holdings Corporation
- Genea Pty Limited
- Hamilton Thorne Ltd.
- SAFE Fertility Center
- Vitrolife AB